XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common stock
Class A Common Stock
Common stock
Class A Common Stock
Conversion Of Stock By Selling Stockholder Upon Initial Public Offering
Common stock
Class A Common Stock
Conversion Of Class B To Class A
Common stock
Class B Common Stock
Common stock
Class B Common Stock
Conversion Of Stock By Selling Stockholder Upon Initial Public Offering
Common stock
Class B Common Stock
Conversion Of Class B To Class A
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stockholders' Equity, beginning balance $ (134,747) $ 0     $ 0     $ 67,168 $ (206,005) $ 4,090 $ 0
Convertible preferred stock, beginning balance (in shares) at Jan. 31, 2020 79,959,000                    
Convertible preferred stock, beginning balance at Jan. 31, 2020 $ 425,146                    
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Issuance of common stock upon conversion of preferred stock (in shares) (408,000)                    
Issuance of common stock upon conversion of preferred stock $ (242)                    
Convertible preferred stock, ending balance (in shares) at Jan. 31, 2021 79,551,000                    
Convertible preferred stock, ending balance at Jan. 31, 2021 $ 424,904                    
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2020   1,151,000     49,338,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Repurchase of common stock (in shares)         (20,000)            
Repurchase of common stock (820)             (820)      
Conversion of stock (in shares)         408,000            
Conversion of stock $ 242             242      
Issuance of common stock related to vested exercised stock options (in shares) 2,862,000       1,876,000            
Issuance of common stock related to vested exercised stock options $ 5,618             5,618      
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)         866,000            
Vesting of early exercised stock options 2,838             2,838      
Stock-based compensation expense 111,846             111,846      
Foreign currency translation adjustments (24,005)                 (24,005)  
Net loss (192,194)               (192,194)    
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2021   1,151,000     52,468,000            
Stockholders' Equity, ending balance at Jan. 31, 2021 (231,222) $ 0     $ 0     186,892 (398,199) (19,915) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stockholders' Equity, beginning balance $ (231,222) $ 0     $ 0     186,892 (398,199) (19,915) 0
Conversion of convertible preferred stock to Class B common stock upon initial public offering (in shares) (79,551,000)                    
Conversion of convertible preferred stock to Class B common stock upon initial public offering $ (424,904)                    
Convertible preferred stock, ending balance (in shares) at Jan. 31, 2022 0                    
Convertible preferred stock, ending balance at Jan. 31, 2022 $ 0                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Repurchase of common stock (in shares)         (13,000)            
Repurchase of common stock (590)             (590)      
Conversion of stock (in shares)     2,500,000 14,550,000 79,551,000 2,500,000 14,550,000        
Conversion of stock 424,904             424,904      
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs (in shares)   8,940,000                  
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs 649,845             649,845      
Issuance of common stock in connection with business combination, net (in shares)         26,000            
Issuance of common stock in connection with business combination, net 959             959      
Contingent stock consideration in connection with business combination $ 1,754             1,754      
Issuance of common stock related to vested exercised stock options (in shares) 4,789,000       4,118,000            
Issuance of common stock related to vested exercised stock options $ 19,408             19,408      
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)         574,000            
Vesting of early exercised stock options 7,212             7,212      
Warrant exercised (in shares)         73,000            
Warrant exercised 86             86      
Stock-based compensation expense 30,009             30,009      
Foreign currency translation adjustments 28,014                 27,639 375
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs 26,450                   26,450
Net loss (157,560)               (155,138)   (2,422)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2022   27,141,000     119,747,000            
Stockholders' Equity, ending balance at Jan. 31, 2022 799,269 [1] $ 0     $ 0     1,320,479 (553,337) 7,724 24,403
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stockholders' Equity, beginning balance $ 799,269 [1] $ 0     $ 0     1,320,479 (553,337) 7,724 24,403
Convertible preferred stock, ending balance (in shares) at Jan. 31, 2023 0                    
Convertible preferred stock, ending balance at Jan. 31, 2023 $ 0                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Conversion of stock (in shares)   66,162,000     66,162,000            
Issuance of common stock related to vested exercised stock options (in shares) 2,964,000       2,940,000            
Issuance of common stock related to vested exercised stock options $ 24,846             24,846      
Issuance of common stock under employee stock purchase plan (in shares)   437,000                  
Issuance of common stock under employee stock purchase plan 14,378             14,378      
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)         36,000            
Issuance of common stock related to RSUs vested, net of tax witholdings (in shares)   915,000                  
Vesting of early exercised stock options 4,706             4,706      
Stock-based compensation expense 122,567             114,811     7,756
Other comprehensive loss (10,729)                 (8,429) (2,300)
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs 61,726             18,153     43,573
Deconsolidation of Meltano Inc. (11,342)                   (11,342)
Net loss (180,696)               (172,311)   (8,385)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2023   94,655,000     56,489,000            
Stockholders' Equity, ending balance at Jan. 31, 2023 824,725 [1] $ 0     $ 0     1,497,373 (725,648) (705) 53,705
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stockholders' Equity, beginning balance $ 824,725 [1] $ 0     $ 0     $ 1,497,373 $ (725,648) $ (705) $ 53,705
[1] (1) As of January 31, 2023 and January 31, 2022, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $62.8 million and $17.7 million, respectively, and liabilities of $8.9 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.